Report Detail

Request for Sample of this report

Medical Industry COVID-19 Impact on Global Human Microbiome Sequencing Technology Market Size, Status and Forecast 2020-2026

  • RnM3970595
    • |
  • 28 May, 2020
    • |
  • Global
    • |
  • 126 Pages
    • |
  • QYResearch
    • |
  • Medical Industry

Human Microbiome Sequencing Technology market is segmented by Technology, and by End Users. Players, stakeholders, and other participants in the global Human Microbiome Sequencing Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Technology and by End Users in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Microbiome Sequencing Technology market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Human Microbiome Sequencing Technology industry.

The key players covered in this study
Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ, Inc.
Illumina, Inc.
Novogene Corporation
OraSure Technologies, Inc.
Oxford Nanopore Technologies, Inc.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Second Genome, Inc.
Thermo Fisher Scientific Inc.
Viome, Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG

Market segment by Technology, the product can be split into
Traditional Sequencing Technologies
Next-Generation Sequencing
Third Generation Sequencing
Market segment by End Users, split into
Research and Academic Institutions
Pharmaceutical and Biotechnology Companies
Hospital and Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Human Microbiome Sequencing Technology status, future forecast, growth opportunity, key market and key players.
To present the Human Microbiome Sequencing Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by technology, market and key regions.

In this study, the years considered to estimate the market size of Human Microbiome Sequencing Technology are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, technology and end users, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Human Microbiome Sequencing Technology Revenue
  • 1.4 Covid-19 Implications on Market by Technology
    • 1.4.1 Global Human Microbiome Sequencing Technology Market Size Growth Rate by Technology: 2020 VS 2026
    • 1.4.2 Traditional Sequencing Technologies
    • 1.4.3 Next-Generation Sequencing
    • 1.4.4 Third Generation Sequencing
  • 1.5 Market by Application
    • 1.5.1 Global Human Microbiome Sequencing Technology Market Share by End Users: 2020 VS 2026
    • 1.5.2 Research and Academic Institutions
    • 1.5.3 Pharmaceutical and Biotechnology Companies
    • 1.5.4 Hospital and Clinic
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Human Microbiome Sequencing Technology Industry Impact
    • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.6.2 Covid-19 Impact: Commodity Prices Indices
    • 1.6.3 Covid-19 Impact: Global Major Government Policy
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends

  • 2.1 Covid-19 Implications on Global Human Microbiome Sequencing Technology Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global Human Microbiome Sequencing Technology Growth Trends by Regions
    • 2.2.1 Human Microbiome Sequencing Technology Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Human Microbiome Sequencing Technology Historic Market Share by Regions (2015-2020)
    • 2.2.3 Human Microbiome Sequencing Technology Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Human Microbiome Sequencing Technology Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Human Microbiome Sequencing Technology Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top Human Microbiome Sequencing Technology Players by Market Size
    • 3.1.1 Global Top Human Microbiome Sequencing Technology Players by Revenue (2015-2020)
    • 3.1.2 Global Human Microbiome Sequencing Technology Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Human Microbiome Sequencing Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Human Microbiome Sequencing Technology Market Concentration Ratio
    • 3.2.1 Global Human Microbiome Sequencing Technology Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Human Microbiome Sequencing Technology Revenue in 2019
  • 3.3 Human Microbiome Sequencing Technology Key Players Head office and Area Served
  • 3.4 Key Players Human Microbiome Sequencing Technology Product Solution and Service
  • 3.5 Date of Enter into Human Microbiome Sequencing Technology Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Technology (2015-2026)

  • 4.1 Global Human Microbiome Sequencing Technology Historic Market Size by Technology (2015-2020)
  • 4.2 Global Human Microbiome Sequencing Technology Forecasted Market Size by Technology (2021-2026)

5 Covid-19 Implications on Market Size by End Users (2015-2026)

  • 5.1 Global Human Microbiome Sequencing Technology Market Size by End Users (2015-2020)
  • 5.2 Global Human Microbiome Sequencing Technology Forecasted Market Size by End Users (2021-2026)

6 North America Impact of COVID-19

  • 6.1 North America Human Microbiome Sequencing Technology Market Size (2015-2020)
  • 6.2 Human Microbiome Sequencing Technology Key Players in North America (2019-2020)
  • 6.3 North America Human Microbiome Sequencing Technology Market Size by Technology (2015-2020)
  • 6.4 North America Human Microbiome Sequencing Technology Market Size by End Users (2015-2020)

7 Europe Impact of COVID-19

  • 7.1 Europe Human Microbiome Sequencing Technology Market Size (2015-2020)
  • 7.2 Human Microbiome Sequencing Technology Key Players in Europe (2019-2020)
  • 7.3 Europe Human Microbiome Sequencing Technology Market Size by Technology (2015-2020)
  • 7.4 Europe Human Microbiome Sequencing Technology Market Size by End Users (2015-2020)

8 China Impact of COVID-19

  • 8.1 China Human Microbiome Sequencing Technology Market Size (2015-2020)
  • 8.2 Human Microbiome Sequencing Technology Key Players in China (2019-2020)
  • 8.3 China Human Microbiome Sequencing Technology Market Size by Technology (2015-2020)
  • 8.4 China Human Microbiome Sequencing Technology Market Size by End Users (2015-2020)

9 Japan Impact of COVID-19

  • 9.1 Japan Human Microbiome Sequencing Technology Market Size (2015-2020)
  • 9.2 Human Microbiome Sequencing Technology Key Players in Japan (2019-2020)
  • 9.3 Japan Human Microbiome Sequencing Technology Market Size by Technology (2015-2020)
  • 9.4 Japan Human Microbiome Sequencing Technology Market Size by End Users (2015-2020)

10 Southeast Asia Impact of COVID-19

  • 10.1 Southeast Asia Human Microbiome Sequencing Technology Market Size (2015-2020)
  • 10.2 Human Microbiome Sequencing Technology Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Human Microbiome Sequencing Technology Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Human Microbiome Sequencing Technology Market Size by Application (2015-2020)

11 India Impact of COVID-19

  • 11.1 India Human Microbiome Sequencing Technology Market Size (2015-2020)
  • 11.2 Human Microbiome Sequencing Technology Key Players in India (2019-2020)
  • 11.3 India Human Microbiome Sequencing Technology Market Size by Type (2015-2020)
  • 11.4 India Human Microbiome Sequencing Technology Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

  • 12.1 Central & South America Human Microbiome Sequencing Technology Market Size (2015-2020)
  • 12.2 Human Microbiome Sequencing Technology Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Human Microbiome Sequencing Technology Market Size by Type (2015-2020)
  • 12.4 Central & South America Human Microbiome Sequencing Technology Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Baseclear B.V.
    • 13.1.1 Baseclear B.V. Company Details
    • 13.1.2 Baseclear B.V. Business Overview and Its Total Revenue
    • 13.1.3 Baseclear B.V. Human Microbiome Sequencing Technology Introduction
    • 13.1.4 Baseclear B.V. Revenue in Human Microbiome Sequencing Technology Business (2015-2020))
    • 13.1.5 Baseclear B.V. Recent Development and Reaction to COVID-19
  • 13.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
    • 13.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Details
    • 13.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Business Overview and Its Total Revenue
    • 13.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Technology Introduction
    • 13.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 13.2.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Development and Reaction to COVID-19
  • 13.3 Charles River Laboratories International Inc.
    • 13.3.1 Charles River Laboratories International Inc. Company Details
    • 13.3.2 Charles River Laboratories International Inc. Business Overview and Its Total Revenue
    • 13.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Technology Introduction
    • 13.3.4 Charles River Laboratories International Inc. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 13.3.5 Charles River Laboratories International Inc. Recent Development and Reaction to COVID-19
  • 13.4 Clinical Microbiomics A/S
    • 13.4.1 Clinical Microbiomics A/S Company Details
    • 13.4.2 Clinical Microbiomics A/S Business Overview and Its Total Revenue
    • 13.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Technology Introduction
    • 13.4.4 Clinical Microbiomics A/S Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 13.4.5 Clinical Microbiomics A/S Recent Development and Reaction to COVID-19
  • 13.5 Eurofins Scientific SE
    • 13.5.1 Eurofins Scientific SE Company Details
    • 13.5.2 Eurofins Scientific SE Business Overview and Its Total Revenue
    • 13.5.3 Eurofins Scientific SE Human Microbiome Sequencing Technology Introduction
    • 13.5.4 Eurofins Scientific SE Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 13.5.5 Eurofins Scientific SE Recent Development and Reaction to COVID-19
  • 13.6 GENEWIZ, Inc.
    • 13.6.1 GENEWIZ, Inc. Company Details
    • 13.6.2 GENEWIZ, Inc. Business Overview and Its Total Revenue
    • 13.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Technology Introduction
    • 13.6.4 GENEWIZ, Inc. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 13.6.5 GENEWIZ, Inc. Recent Development and Reaction to COVID-19
  • 13.7 Illumina, Inc.
    • 13.7.1 Illumina, Inc. Company Details
    • 13.7.2 Illumina, Inc. Business Overview and Its Total Revenue
    • 13.7.3 Illumina, Inc. Human Microbiome Sequencing Technology Introduction
    • 13.7.4 Illumina, Inc. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 13.7.5 Illumina, Inc. Recent Development and Reaction to COVID-19
  • 13.8 Novogene Corporation
    • 13.8.1 Novogene Corporation Company Details
    • 13.8.2 Novogene Corporation Business Overview and Its Total Revenue
    • 13.8.3 Novogene Corporation Human Microbiome Sequencing Technology Introduction
    • 13.8.4 Novogene Corporation Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 13.8.5 Novogene Corporation Recent Development and Reaction to COVID-19
  • 13.9 OraSure Technologies, Inc.
    • 13.9.1 OraSure Technologies, Inc. Company Details
    • 13.9.2 OraSure Technologies, Inc. Business Overview and Its Total Revenue
    • 13.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Technology Introduction
    • 13.9.4 OraSure Technologies, Inc. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 13.9.5 OraSure Technologies, Inc. Recent Development and Reaction to COVID-19
  • 13.10 Oxford Nanopore Technologies, Inc.
    • 13.10.1 Oxford Nanopore Technologies, Inc. Company Details
    • 13.10.2 Oxford Nanopore Technologies, Inc. Business Overview and Its Total Revenue
    • 13.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Technology Introduction
    • 13.10.4 Oxford Nanopore Technologies, Inc. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 13.10.5 Oxford Nanopore Technologies, Inc. Recent Development and Reaction to COVID-19
  • 13.11 Pacific Biosciences of California, Inc.
    • 10.11.1 Pacific Biosciences of California, Inc. Company Details
    • 10.11.2 Pacific Biosciences of California, Inc. Business Overview and Its Total Revenue
    • 10.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Technology Introduction
    • 10.11.4 Pacific Biosciences of California, Inc. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 10.11.5 Pacific Biosciences of California, Inc. Recent Development and Reaction to COVID-19
  • 13.12 QIAGEN N.V.
    • 10.12.1 QIAGEN N.V. Company Details
    • 10.12.2 QIAGEN N.V. Business Overview and Its Total Revenue
    • 10.12.3 QIAGEN N.V. Human Microbiome Sequencing Technology Introduction
    • 10.12.4 QIAGEN N.V. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 10.12.5 QIAGEN N.V. Recent Development and Reaction to COVID-19
  • 13.13 Second Genome, Inc.
    • 10.13.1 Second Genome, Inc. Company Details
    • 10.13.2 Second Genome, Inc. Business Overview and Its Total Revenue
    • 10.13.3 Second Genome, Inc. Human Microbiome Sequencing Technology Introduction
    • 10.13.4 Second Genome, Inc. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 10.13.5 Second Genome, Inc. Recent Development and Reaction to COVID-19
  • 13.14 Thermo Fisher Scientific Inc.
    • 10.14.1 Thermo Fisher Scientific Inc. Company Details
    • 10.14.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
    • 10.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Technology Introduction
    • 10.14.4 Thermo Fisher Scientific Inc. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 10.14.5 Thermo Fisher Scientific Inc. Recent Development and Reaction to COVID-19
  • 13.15 Viome, Inc.
    • 10.15.1 Viome, Inc. Company Details
    • 10.15.2 Viome, Inc. Business Overview and Its Total Revenue
    • 10.15.3 Viome, Inc. Human Microbiome Sequencing Technology Introduction
    • 10.15.4 Viome, Inc. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 10.15.5 Viome, Inc. Recent Development and Reaction to COVID-19
  • 13.16 CosmosID
    • 10.16.1 CosmosID Company Details
    • 10.16.2 CosmosID Business Overview and Its Total Revenue
    • 10.16.3 CosmosID Human Microbiome Sequencing Technology Introduction
    • 10.16.4 CosmosID Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 10.16.5 CosmosID Recent Development and Reaction to COVID-19
  • 13.17 Leucine Rich Bio Pvt. Ltd.
    • 10.17.1 Leucine Rich Bio Pvt. Ltd. Company Details
    • 10.17.2 Leucine Rich Bio Pvt. Ltd. Business Overview and Its Total Revenue
    • 10.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Technology Introduction
    • 10.17.4 Leucine Rich Bio Pvt. Ltd. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 10.17.5 Leucine Rich Bio Pvt. Ltd. Recent Development and Reaction to COVID-19
  • 13.18 Microba
    • 10.18.1 Microba Company Details
    • 10.18.2 Microba Business Overview and Its Total Revenue
    • 10.18.3 Microba Human Microbiome Sequencing Technology Introduction
    • 10.18.4 Microba Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 10.18.5 Microba Recent Development and Reaction to COVID-19
  • 13.19 Microbiome Insights Inc.
    • 10.19.1 Microbiome Insights Inc. Company Details
    • 10.19.2 Microbiome Insights Inc. Business Overview and Its Total Revenue
    • 10.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Technology Introduction
    • 10.19.4 Microbiome Insights Inc. Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 10.19.5 Microbiome Insights Inc. Recent Development and Reaction to COVID-19
  • 13.20 Molzym GmbH & Co. KG
    • 10.20.1 Molzym GmbH & Co. KG Company Details
    • 10.20.2 Molzym GmbH & Co. KG Business Overview and Its Total Revenue
    • 10.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Technology Introduction
    • 10.20.4 Molzym GmbH & Co. KG Revenue in Human Microbiome Sequencing Technology Business (2015-2020)
    • 10.20.5 Molzym GmbH & Co. KG Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Human Microbiome Sequencing Technology. Industry analysis & Market Report on Human Microbiome Sequencing Technology is a syndicated market report, published as COVID-19 Impact on Global Human Microbiome Sequencing Technology Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Human Microbiome Sequencing Technology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,014.70
    		4,522.05
    		6,029.40
    		3,630.90
    		5,446.35
    		7,261.80
    		595,491.00
    		893,236.50
    		1,190,982.00
    		329,160.00
    		493,740.00
    		658,320.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo